Cipla zooms 9% on stronger-than-expected Q1; brokerages cheer, raise targets
Shares of major pharmaceutical company Cipla rose nearly 9% in early trading on July 27 after the company’s earnings for the April-June period beat expectations. Some brokerages also raised their price targets on the stock as they applauded the company’s impressive numbers for the quarter under review. While the company’s net income and revenue for …
Cipla zooms 9% on stronger-than-expected Q1; brokerages cheer, raise targets Read More »